Marc Tessier-Lavigne, the executive vice president for research and the chief scientific officer at Genentech, is leaving the company to take the helm of Rockefeller University in New York, reports the New York Times. Tessier-Lavigne will take up the position in March, succeeding Paul Nurse, who is returning to the UK to lead the Royal Society there.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.